|
|
||||||||
a Division of Cardiac Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, Canada
b Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, Canada
Accepted for publication October 8, 2008.
* Address correspondence to Dr Cheung, Division of Cardiac Surgery, St. Paul's Hospital, 1081 Burrard St, Vancouver, British Columbia, V6Z 1Y6, Canada (Email: acheung{at}providencehealth.bc.ca).
| Dr Cheung discloses that he has a financial relationship with Edwards Lifesciences, Medtronic Inc, Atricure, and St. Jude Medical; Dr Webb with Edwards Lifesciences.
|
| Abstract |
|---|
|
|
|---|
Transcatheter aortic valve implantation, both transfemoral and transapical, has been performed in high-risk patients with native and prosthetic aortic stenosis [1–4]. Transcatheter valves have also been implanted in bioprosthetic mitral valves in swine [5]. We report a transcatheter mitral valve-in-valve implant in a patient.
An 80-year-old man presented with progressive dyspnea. Seven years ago, he underwent mitral valve replacement with chordal preservation using a 25-mm bioprosthesis (Carpentier-Edwards PERIMOUNT Plus 6900P valve; Edwards Lifesciences LLC, Irvine, CA) for degenerative mitral regurgitation (MR), with concomitant coronary artery bypass grafts. Comorbid conditions included previous myocardial infarction, chronic obstructive pulmonary disease, and chronic renal insufficiency (creatinine, 170 µmol/L).
Echocardiography revealed severe prosthetic mitral stenosis (valve area, 0.7 cm2; mean gradient, 17 mm Hg) with elevated pulmonary artery systolic pressure (90 mm Hg). Ejection fraction was 0.65. The sewing ring inner diameter measured 24 mm by transesophageal echocardiogram (TEE). All bypass grafts were patent.
The Society of Thoracic Surgeons (STS) score predicted a 20.6% risk of death for redo mitral valve replacement, and the patient consented to transcatheter mitral valve-in-valve implantation after twice being refused conventional reoperation. The procedure was approved by the Institutional Review Board.
Concerned about difficulty crossing the stenotic bioprosthesis retrogradely and entanglement within the preserved chords, we first attempted an antegrade approach through the left atrium, using a right anterior minithoracotomy, but were unable to cross the xenograft. This approach was abandoned.
A left anterior minithoracotomy through the sixth intercostal space was centered over the left ventricular (LV) apex. Two pledgetted sutures were placed apically for control. The mitral valve was easily crossed, and the wire was advanced into the pulmonary veins for anchoring. This approach provided a direct shot from apex to valve (Fig 1a).
|
|
|
| Comment |
|---|
|
|
|---|
Case selection remains crucial. The transapical approach offers direct access with excellent device stability. Nevertheless, future attempts at an antegrade approach through the lower-pressure chamber may still be warranted.
Valve-in-valve procedures differ from implants in native valves because the rigid xenograft substitutes for the leaflet and annular calcification required for stability while providing a ready fluoroscopic landing marker, simplifying positioning. Although acoustic shadowing can hinder echocardiographic visualization, in our experience this did not hamper positioning. The nondistensible support ring especially necessitates accurate sizing of the Edwards valve, currently only available in 23- and 26-mm models. We used a cuffed device for the valve-in-valve implant to provide a better seal within the rigid support ring, minimizing paraprosthetic leak.
Valve-in-valve procedures may increasingly supplant conventional redo valve procedures, even among lower-risk patients. Furthermore, transcatheter valves may be deployed within transcatheter valves, eliminating the need for repeat reoperations. These developments may mark a tipping point toward increased use of bioprosthetic valves and a pivotal change in the management of valvular disease.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Piazza, S. Bleiziffer, G. Brockmann, R. Hendrick, M.-A. Deutsch, A. Opitz, D. Mazzitelli, P. Tassani-Prell, C. Schreiber, and R. Lange Transcatheter Aortic Valve Implantation for Failing Surgical Aortic Bioprosthetic Valve: From Concept to Clinical Application and Evaluation (Part 1) J. Am. Coll. Cardiol. Intv., July 1, 2011; 4(7): 721 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cheung, R. Gurvitch, J. Ye, D. Wood, S. V. Lichtenstein, C. Thompson, and J. G. Webb Transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis: A case series J. Thorac. Cardiovasc. Surg., March 1, 2011; 141(3): 711 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. F. Hon, A. Cheung, J. Ye, R. G. Carere, B. Munt, K. Josan, S. V. Lichtenstein, and J. Webb Transatrial Transcatheter Tricuspid Valve-in-Valve Implantation of Balloon Expandable Bioprosthesis Ann. Thorac. Surg., November 1, 2010; 90(5): 1696 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Van Mieghem, N. Piazza, R. H. Anderson, A. Tzikas, K. Nieman, L. E. De Laat, J. S. McGhie, M. L. Geleijnse, T. Feldman, P. W. Serruys, et al. Anatomy of the Mitral Valvular Complex and Its Implications for Transcatheter Interventions for Mitral Regurgitation J. Am. Coll. Cardiol., August 17, 2010; 56(8): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lozonschi, R. Bombien, S. Osaki, J. Hu, D. Snell, N. M. Edwards, J. Cremer, and G. Lutter Transapical mitral valved stent implantation: A survival series in swine J. Thorac. Cardiovasc. Surg., August 1, 2010; 140(2): 422 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Azadani, N. Jaussaud, P. B. Matthews, L. Ge, T. A. M. Chuter, and E. E. Tseng Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses Interact CardioVasc Thorac Surg, July 1, 2010; 11(1): 70 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Webb, D. A. Wood, J. Ye, R. Gurvitch, J. B. Masson, J. Rodes-Cabau, M. Osten, E. Horlick, O. Wendler, E. Dumont, et al. Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves Circulation, April 27, 2010; 121(16): 1848 - 1857. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |